Skip to main content
Dartmouth-Hitchcock logo
Summer Flowers In This Section
Treatments Against RA and Effect on FDG PET-CT: The TARGET Trial
Principal Investigator (?)
Study Number
In a randomized controlled clinical trial, investigators will compare the effects on [18F]-fluorodeoxyglucose positron emission tomography-computed tomography (FDG PET/CT) from two treatment regimens in rheumatoid arthritis (RA) patients deemed methotrexate inadequate responders (MTX-IRs). Two common RA treatments will be compared: triple therapy (sulfasalazine, methotrexate, and hydroxychloroquine) versus tumor necrosis factor (TNF) inhibitor (etanercept or adalimumab, plus background methotrexate for all subjects and hydroxychloroquine for subjects who were taking this at screening). 
Phase (?)
Phase III
Available at the following location(s)


View more details from